Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Pharmaceutical service provider receives prestigious management award for the seventh year in a row.
Released By Vetter Pharma International
May 27, 2026
Vetter, a leading Contract Development and Manufacturing Organization (CDMO), has been named a Best Managed Company for the seventh year in a row. The family-owned business was the only company in this year’s competition to be newly awarded Platinum status. The prestigious prize is awarded by Deloitte Private, UBS, Frankfurter Allgemeine Zeitung and the Bundesverband der Deutschen Industrie e.V. (Federation of German Industries, BDI) to companies for outstanding achievements in leadership and management. The jury evaluates companies according to four value drivers: strategy, productivity, culture and commitment, and governance and finance. In 2026, the CDMO received the award primarily for consistent further development of its corporate strategy and its operational processes in the context of a globally challenging environment. The trophy and certificate were presented to Vetter at an awards ceremony on May 21 at the Gesellschaftshaus Palmengarten in Frankfurt, Germany.
The jury was particularly impressed by the company’s consistent and ongoing strategic efforts: The successful completion of the current Vetter NExT 2029 strategic program lays a solid foundation for developing and finalizing a new, forward-looking program this year. Vetter also stood out for its clear focus on achieving ambitious climate protection targets and its ongoing development of integrated corporate reporting and risk management, which strengthens its permanent ability to act. This enables the CDMO to act with foresight and reliability, even in times of geopolitical uncertainties and their potential impact on supply chains, energy supply and other external conditions.
“Being once again recognized as a Best Managed Company underscores the strength and resilience of our strategic corporate direction,” says Senator h.c. Udo J. Vetter, Chairman of the Advisory Board and member of the owner family. “Our sustainable growth is the result of long-term thinking and investments in our service portfolio, and the required infrastructure. In this way, we consistently pursue our goal of supplying patients worldwide with vital medicines – and improving their quality of life every day.” Vetter Managing Director Titus Ottinger adds: “Another key area of investment for us is in the digitalization of our value-added corporate processes. The potential impact is significant. So is our core objective: to reduce the number of manual interfaces, create more seamless data flows, and increase data integrity – without compromising on compliance. In this way, we are strengthening our position as a leader in quality and technology as well as our customers’ long-term trust in us.”
The jury also recognized Vetter’s clearly defined, ambitious climate targets, through which the company is systematically working to reduce its CO2 emissions, among other initiatives. The CDMO successfully combines environmental responsibility with economic success. In addition, the jury highlighted the company’s comprehensive commitment to securing skilled workers and employee development. Through innovative approaches such as the Integrative Entry Program, Vetter taps into additional skilled worker potential and enables successful qualification, language training and integration. The company-wide rollout of its digital platform Vetter Learning deliberately places a clear focus on lifelong learning, knowledge transfer and the continuous professional development of its employees.
Markus Seiz, Head of the Best Managed Companies (BMC) Program in Germany at Deloitte Private, emphasizes: “We have been working with Vetter for many years now, and we are impressed by the intensity and consistency with which the management and employees engage in strategic processes. The pharmaceutical service provider is also an excellent example of how the application process itself can be used as a source of additional momentum for the company.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !